Kady Phe

553 total citations
17 papers, 400 citations indexed

About

Kady Phe is a scholar working on Pharmacology, Epidemiology and Applied Microbiology and Biotechnology. According to data from OpenAlex, Kady Phe has authored 17 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmacology, 6 papers in Epidemiology and 6 papers in Applied Microbiology and Biotechnology. Recurrent topics in Kady Phe's work include Antibiotics Pharmacokinetics and Efficacy (13 papers), Antibiotic Use and Resistance (6 papers) and Antibiotic Resistance in Bacteria (5 papers). Kady Phe is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (13 papers), Antibiotic Use and Resistance (6 papers) and Antibiotic Resistance in Bacteria (5 papers). Kady Phe collaborates with scholars based in United States, Australia and New Zealand. Kady Phe's co-authors include Vincent H. Tam, Patrick M. McDaneld, Nishant Prasad, Jessica Cottreau, Taijun Yin, Ming Hu, William L. Musick, Emily L. Heil, Ana María Sánchez‐Díaz and Jian Zhou and has published in prestigious journals such as The Journal of Infectious Diseases, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Kady Phe

16 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kady Phe United States	11	268	234	196	107	32	17	400
Syamhanin Adnan Australia	6	247 0.9×	145 0.6×	140 0.7×	153 1.4×	47 1.5×	6	383
Patrick M. McDaneld United States	9	179 0.7×	186 0.8×	123 0.6×	106 1.0×	42 1.3×	17	353
Chi-Chang Huang Taiwan	9	92 0.3×	208 0.9×	161 0.8×	102 1.0×	67 2.1×	14	429
Francisco Moreno-Ramos Spain	9	106 0.4×	205 0.9×	88 0.4×	148 1.4×	55 1.7×	21	334
Angela Cheng United States	6	330 1.2×	220 0.9×	188 1.0×	145 1.4×	64 2.0×	8	460
Kathryn J. Eagye United States	14	196 0.7×	189 0.8×	142 0.7×	138 1.3×	66 2.1×	25	452
Angela Loo United States	10	170 0.6×	151 0.6×	151 0.8×	152 1.4×	55 1.7×	19	446
Daniel Eiras United States	9	117 0.4×	143 0.6×	113 0.6×	88 0.8×	33 1.0×	17	371
Christopher Bruno United States	12	302 1.1×	357 1.5×	252 1.3×	192 1.8×	30 0.9×	37	527
Alan Abdulla Netherlands	11	436 1.6×	131 0.6×	226 1.2×	131 1.2×	89 2.8×	34	513

Countries citing papers authored by Kady Phe

Since Specialization

Citations

This map shows the geographic impact of Kady Phe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kady Phe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kady Phe more than expected).

Fields of papers citing papers by Kady Phe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kady Phe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kady Phe. The network helps show where Kady Phe may publish in the future.

Co-authorship network of co-authors of Kady Phe

This figure shows the co-authorship network connecting the top 25 collaborators of Kady Phe. A scholar is included among the top collaborators of Kady Phe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kady Phe. Kady Phe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Phe, Kady, et al.. (2025). Reduction of Vancomycin-Associated Acute Kidney Injury With Montelukast. The Journal of Infectious Diseases. 232(1). 191–198. 1 indexed citations

Phe, Kady, et al.. (2025). P-1772. Reduction in Vancomycin-Associated Acute Kidney Injury with Montelukast. Open Forum Infectious Diseases. 12(Supplement_1).

Phe, Kady, et al.. (2023). The emergence of cefiderocol resistance in Pseudomonas aeruginosa from a heteroresistant isolate during prolonged therapy. Antimicrobial Agents and Chemotherapy. 68(1). e0100923–e0100923. 15 indexed citations

Fukuta, Yuriko, et al.. (2022). Infectious Diseases Management in Wound Care Settings: Common Causative Organisms and Frequently Prescribed Antibiotics. Advances in Skin & Wound Care. 35(10). 535–543. 7 indexed citations

Phe, Kady, et al.. (2021). An integrated approach to evaluate different tetracycline derivatives for formulary decisions. American Journal of Health-System Pharmacy. 79(6). 467–471. 1 indexed citations

Phe, Kady, Emily L. Heil, & Vincent H. Tam. (2020). Optimizing Pharmacokinetics-Pharmacodynamics of Antimicrobial Management in Patients with Sepsis: A Review. The Journal of Infectious Diseases. 222(Supplement_2). S132–S141. 25 indexed citations

Trautner, Barbara W., et al.. (2020). Using clinical decision support to improve urine culture diagnostic stewardship, antimicrobial stewardship, and financial cost: A multicenter experience. Infection Control and Hospital Epidemiology. 41(5). 564–570. 30 indexed citations

Gonzales-Luna, Anne J, Travis J Carlson, Natalie A. Finch, et al.. (2019). Significant Publications on Infectious Diseases Pharmacotherapy in 2018. Journal of Pharmacy Practice. 32(5). 546–557. 15 indexed citations

Phe, Kady, et al.. (2018). Outcomes of empiric aminoglycoside monotherapy for Pseudomonas aeruginosa bacteremia. Diagnostic Microbiology and Infectious Disease. 93(4). 346–348. 6 indexed citations

10.

Foolad, Farnaz, et al.. (2018). Significant Publications on Infectious Diseases Pharmacotherapy in 2017. Journal of Pharmacy Practice. 32(5). 534–545. 13 indexed citations

11.

Tam, Vincent H., Kai‐Tai Chang, Jian Zhou, et al.. (2017). Determining β-lactam exposure threshold to suppress resistance development in Gram-negative bacteria. Journal of Antimicrobial Chemotherapy. 72(5). 1421–1428. 76 indexed citations

12.

Phe, Kady, et al.. (2017). Significant Publications on Infectious Diseases Pharmacotherapy in 2016. Journal of Pharmacy Practice. 31(5). 469–480. 14 indexed citations

13.

Phe, Kady, et al.. (2016). Predicting the risk of nephrotoxicity in patients receiving colistimethate sodium: a multicentre, retrospective, cohort study: Table 1.. Journal of Antimicrobial Chemotherapy. 71(12). 3585–3587. 13 indexed citations

14.

Phe, Kady, et al.. (2016). An institutional review of antimicrobial stewardship interventions. Journal of Global Antimicrobial Resistance. 6. 75–77. 10 indexed citations

15.

Phe, Kady, et al.. (2015). Significant publications on infectious diseases pharmacotherapy in 2014. American Journal of Health-System Pharmacy. 72(16). 1380–1392. 8 indexed citations

16.

Phe, Kady, Patrick M. McDaneld, Nishant Prasad, et al.. (2014). In Vitro Assessment and Multicenter Cohort Study of Comparative Nephrotoxicity Rates Associated with Colistimethate versus Polymyxin B Therapy. Antimicrobial Agents and Chemotherapy. 58(5). 2740–2746. 153 indexed citations

17.

Phe, Kady, Michael L. Johnson, Hannah R. Palmer, & Vincent H. Tam. (2014). Validation of a Model To Predict the Risk of Nephrotoxicity in Patients Receiving Colistin. Antimicrobial Agents and Chemotherapy. 58(11). 6946–6948. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact